Investor Backing & Capital Strength:
Funding of a $29M Series A led by Sapphire Ventures is presented as providing resources to scale product and go-to-market. This capital raise is cited alongside ongoing hiring and expansion activities.
Product Line Growth:
Launches of the 'Billie' AI agent for billing and later eligibility features, followed by the 2026 Pledge Health acquisition, are described as broadening the platform and extending automation into pre-service workflows. These moves expand the upsell surface and end-to-end coverage.
Market Expansion:
Partnerships such as being named a preferred partner by CentralReach and references to use across 3,000+ facilities indicate meaningful penetration and distribution. Company communications also highlight rising daily patient engagement and active recruiting as demand signals.
